UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Steady-State Kinetics of Enzyme-Catalyzed Hydrolysis of Echothiophate, a P-S Bonded Organophosphorus as Monitored by Spectrofluorimetry

Molecules (Basel, Switzerland), 2020-03, Vol.25 (6), p.1371

2020

Volltextzugriff (PDF)

Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease

Molecules (Basel, Switzerland), 2022-11, Vol.27 (22), p.7855

2022

Volltextzugriff (PDF)

Can Activation of Acetylcholinesterase by β-Amyloid Peptide Decrease the Effectiveness of Cholinesterase Inhibitors?

International journal of molecular sciences, 2023-11, Vol.24 (22), p.16395

2023

Volltextzugriff (PDF)

Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment

Biochemical journal, 2016-05, Vol.473 (9), p.1225-1236

2016

Volltextzugriff (PDF)

Synthesis and Cholinesterase Inhibitory Potency of 2,3-Indolo-oleanolic Acid and Some Related Derivatives

MolBank, 2023-10, Vol.2023 (4), p.M1739

2023

Volltextzugriff (PDF)

Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease

Molecules (Basel, Switzerland), 2020-09, Vol.25 (18), p.4191

2020

Volltextzugriff (PDF)

Oxime Therapy for Brain AChE Reactivation and Neuroprotection after Organophosphate Poisoning

Pharmaceutics, 2022-09, Vol.14 (9), p.1950

2022

Volltextzugriff (PDF)

1-(3- Tert -Butylphenyl)-2,2,2-Trifluoroethanone as a Potent Transition-State Analogue Slow-Binding Inhibitor of Human Acetylcholinesterase: Kinetic, MD and QM/MM Studies

Biomolecules (Basel, Switzerland), 2020-11, Vol.10 (12), p.1608

2020

Volltextzugriff (PDF)

Therapy of Organophosphate Poisoning via Intranasal Administration of 2-PAM-Loaded Chitosomes

Pharmaceutics, 2022-12, Vol.14 (12), p.2846

2022

Volltextzugriff (PDF)

Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning

Scientific reports, 2020-10, Vol.10 (1), p.16611, Article 16611

2020

Volltextzugriff (PDF)

Mixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model

Colloids and surfaces, B, Biointerfaces, 2018-11, Vol.171, p.358-367

2018

Volltextzugriff (PDF)

Biomedical potentialities of cationic geminis as modulating agents of liposome in drug delivery across biological barriers and cellular uptake

International journal of pharmaceutics, 2020-09, Vol.587, p.119640, Article 119640

2020

Volltextzugriff (PDF)

Surface modification of pralidoxime chloride-loaded solid lipid nanoparticles for enhanced brain reactivation of organophosphorus-inhibited AChE: Pharmacokinetics in rat

Toxicology (Amsterdam), 2020-11, Vol.444, p.152578, Article 152578

2020

Volltextzugriff (PDF)

Bi-functional sterically hindered phenol lipid-based delivery systems as potential multi-target agents against Alzheimer's disease via an intranasal route

Nanoscale, 2020-07, Vol.12 (25), p.13757-13770

2020

Volltextzugriff (PDF)

A new sensitive spectrofluorimetric method for measurement of activity and kinetic study of cholinesterases

Biochimica et biophysica acta. Proteins and proteomics, 2020-01, Vol.1868 (1), p.140270, Article 140270

2020

Volltextzugriff (PDF)

Combination delivery of two oxime-loaded lipid nanoparticles: Time-dependent additive action for prolonged rat brain protection

Journal of controlled release, 2018-11, Vol.290, p.102-111

2018

Volltextzugriff (PDF)

Nanoparticle-Delivered 2‑PAM for Rat Brain Protection against Paraoxon Central Toxicity

ACS applied materials & interfaces, 2017-05, Vol.9 (20), p.16922-16932

2017

Volltextzugriff (PDF)

Water structure changes in oxime-mediated reactivation process of phosphorylated human acetylcholinesterase

Bioscience reports, 2018-06, Vol.38 (3)

2018

Volltextzugriff (PDF)

Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning

European journal of medicinal chemistry, 2023-01, Vol.246, p.114949, Article 114949

2023

Volltextzugriff (PDF)

Computer-designed active human butyrylcholinesterase double mutant with a new catalytic triad

Chemico-biological interactions, 2019-06, Vol.306, p.138-146

2019

Volltextzugriff (PDF)

6-Methyluracil derivatives as peripheral site ligand-hydroxamic acid conjugates: Reactivation for paraoxon-inhibited acetylcholinesterase

European journal of medicinal chemistry, 2020-01, Vol.185, p.111787-111787, Article 111787

2020

Volltextzugriff (PDF)

Conjugates of nucleobases with triazole-hydroxamic acids for the reactivation of acetylcholinesterase and treatment of delayed neurodegeneration induced by organophosphate poisoning

Bioorganic chemistry, 2023-12, Vol.141, p.106858-106858, Article 106858

2023

Volltextzugriff (PDF)

Specific inhibition of acetylcholinesterase as an approach to decrease muscarinic side effects during myasthenia gravis treatment

Scientific reports, 2018-01, Vol.8 (1), p.304-304, Article 304

2018

Volltextzugriff (PDF)

Water-soluble betaines and amines based on thiacalix[4]arene scaffold as new cholinesterase inhibitors

Bioorganic chemistry, 2020-01, Vol.94, p.103455, Article 103455

2020

Volltextzugriff (PDF)

Novel potent pyridoxine-based inhibitors of AChE and BChE, structural analogs of pyridostigmine, with improved in vivo safety profile

Bioorganic & medicinal chemistry letters, 2016-08, Vol.26 (16), p.4092-4094

2016

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Deutsch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Steady-State Kinetics of Enzyme-Catalyzed Hydrolysis of Echothiophate, a P-S Bonded Organophosphorus as Monitored by Spectrofluorimetry

Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease

Can Activation of Acetylcholinesterase by β-Amyloid Peptide Decrease the Effectiveness of Cholinesterase Inhibitors?

Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment

Synthesis and Cholinesterase Inhibitory Potency of 2,3-Indolo-oleanolic Acid and Some Related Derivatives

Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease

Oxime Therapy for Brain AChE Reactivation and Neuroprotection after Organophosphate Poisoning

1-(3- Tert -Butylphenyl)-2,2,2-Trifluoroethanone as a Potent Transition-State Analogue Slow-Binding Inhibitor of Human Acetylcholinesterase: Kinetic, MD and QM/MM Studies

Therapy of Organophosphate Poisoning via Intranasal Administration of 2-PAM-Loaded Chitosomes

Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning

Mixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model

Biomedical potentialities of cationic geminis as modulating agents of liposome in drug delivery across biological barriers and cellular uptake

Surface modification of pralidoxime chloride-loaded solid lipid nanoparticles for enhanced brain reactivation of organophosphorus-inhibited AChE: Pharmacokinetics in rat

Bi-functional sterically hindered phenol lipid-based delivery systems as potential multi-target agents against Alzheimer's disease via an intranasal route

A new sensitive spectrofluorimetric method for measurement of activity and kinetic study of cholinesterases

Combination delivery of two oxime-loaded lipid nanoparticles: Time-dependent additive action for prolonged rat brain protection

Nanoparticle-Delivered 2‑PAM for Rat Brain Protection against Paraoxon Central Toxicity

Water structure changes in oxime-mediated reactivation process of phosphorylated human acetylcholinesterase

Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning

Computer-designed active human butyrylcholinesterase double mutant with a new catalytic triad

6-Methyluracil derivatives as peripheral site ligand-hydroxamic acid conjugates: Reactivation for paraoxon-inhibited acetylcholinesterase

Conjugates of nucleobases with triazole-hydroxamic acids for the reactivation of acetylcholinesterase and treatment of delayed neurodegeneration induced by organophosphate poisoning

Specific inhibition of acetylcholinesterase as an approach to decrease muscarinic side effects during myasthenia gravis treatment

Water-soluble betaines and amines based on thiacalix[4]arene scaffold as new cholinesterase inhibitors

Novel potent pyridoxine-based inhibitors of AChE and BChE, structural analogs of pyridostigmine, with improved in vivo safety profile

Suchergebnisse filtern